H. Feng

Tctex-1, a Novel Interaction Partner of Rab3D, Is Required for Osteoclastic Bone Resorption

C. Sung, R. Jahn, N. Pavlos, 2011, Molecular and Cellular Biology.

Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL‐induced activation of NF‐κB and ERK

J. Steer, N. Pavlos, Jiake Xu, 2012, Journal of cellular biochemistry.

SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation.

N. Pavlos, Qiong Gu, Jun Xu, 2013, Biochemical pharmacology.

Sesquiterpene Lactone Parthenolide Blocks Lipopolysaccharide‐Induced Osteolysis Through the Suppression of NF‐κB Activity

J. Steer, Jiake Xu, M. Zheng, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bafilomycin A1 Attenuates Osteoclast Acidification and Formation, Accompanied by Increased Levels of SQSTM1/p62 Protein

Hua-zi Xu, J. Walsh, N. Pavlos, 2016, Journal of cellular biochemistry.

Deficiency of sorting nexin 10 prevents bone erosion in collagen-induced mouse arthritis through promoting NFATc1 degradation

W. Shen, Chun Zhou, Jiake Xu, 2015, Annals of the rheumatic diseases.

Disruption of the dynein‐dynactin complex unveils motor‐specific functions in osteoclast formation and bone resorption

N. Pavlos, Jiake Xu, E. Khor, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation

A. Qin, Xixi Lin, Jiake Xu, 2016, Scientific Reports.

Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis.

Jinmin Zhao, Jiake Xu, Ge Zhang, 2017, Current drug targets.

Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.

N. Pavlos, M. Zheng, J. Xu, 2007, Histology and histopathology.